PUBLISHER: The Business Research Company | PRODUCT CODE: 2149460
PUBLISHER: The Business Research Company | PRODUCT CODE: 2149460
Cardiac monitoring devices refer to medical devices used to continuously or intermittently monitor heart activity, including heart rate, rhythm, and electrical signals. These devices are used to provide accurate and real-time cardiac data for diagnosing, treating, and managing cardiovascular conditions across hospitals, clinics, and home healthcare settings.
The primary device types of cardiac monitoring devices include electrocardiogram monitors, insertable cardiac monitors, Holter monitors, event recorders, mobile cardiac telemetry, smart wearables, and other device types. Electrocardiogram monitors refer to medical devices that continuously or intermittently record the electrical activity of the heart to detect abnormalities, assess cardiac function, and support clinical diagnosis. These devices are available as wired devices and wireless and wearable devices and are designed for pediatric, adult, and geriatric patients. The various applications include arrhythmia detection, atrial fibrillation monitoring, heart failure management, and sports cardiac monitoring, and they are utilized by end users including healthcare providers, diagnostic laboratories, research institutes, and others.
Tariffs are influencing the cardiac monitoring devices market by increasing the cost of imported medical device components, electronic sensors, semiconductors, and manufacturing equipment required for cardiac monitoring solutions. The impact is significant across wearable devices, mobile cardiac telemetry systems, electrocardiogram monitors, and implantable monitoring devices, particularly in regions dependent on imports such as North America, Europe, and Asia-Pacific. Higher tariffs are increasing manufacturing costs and affecting pricing for healthcare providers, diagnostic laboratories, and research institutions. However, tariffs are also encouraging localized medical device production, regional supply chain diversification, and investments in domestic healthcare technology manufacturing.
The cardiac monitoring devices market research report is one of a series of new reports from The Business Research Company that provides cardiac monitoring devices market statistics, including cardiac monitoring devices industry global market size, regional shares, competitors with a cardiac monitoring devices market share, detailed cardiac monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac monitoring devices industry. This cardiac monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac monitoring devices market size has grown strongly in recent years. It will grow from $25.91 billion in 2025 to $28.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases worldwide, growing aging population requiring cardiac care, rising adoption of cardiac monitoring devices in hospitals and clinics, expanding healthcare infrastructure development, and increasing demand for early diagnosis and preventive cardiac care.
The cardiac monitoring devices market size is expected to see strong growth in the next few years. It will grow to $38.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring solutions, growing adoption of wearable cardiac monitoring devices, rising healthcare digitization and remote patient monitoring services, expanding demand for personalized cardiac care solutions, and increasing focus on continuous cardiovascular disease management. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions for continuous patient care, growing demand for portable and wearable cardiac monitoring devices, rising focus on early detection and management of cardiovascular diseases, expansion of home-based cardiac monitoring and decentralized healthcare services, and increasing integration of advanced sensor technologies in cardiac monitoring devices.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the cardiac monitoring devices market in the coming years. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attack, stroke, and hypertension. The prevalence of cardiovascular diseases is increasing due to unhealthy lifestyle habits such as poor diet, physical inactivity, smoking, and excessive alcohol consumption, along with rising obesity, diabetes, stress, and an aging population. Cardiac monitoring devices support the early detection, continuous monitoring, and timely clinical intervention of cardiovascular diseases by providing real-time cardiac data that improves diagnosis and treatment decisions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, approximately one in six cardiovascular disease deaths occurred among adults younger than 65 years. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the cardiac monitoring devices market.
Major companies operating in the cardiac monitoring devices market are increasingly focusing on developing innovative products, such as wearable cardiac monitoring systems, to facilitate continuous cardiac rhythm monitoring, improve diagnostic accuracy, and enhance patient adherence. Wearable cardiac monitoring systems are compact medical devices designed to continuously record electrocardiogram (ECG) activity and wirelessly transmit cardiac data for clinical assessment, offering a more convenient and efficient alternative to conventional Holter monitors, which often require manual data retrieval and device return. For instance, in April 2026, RhythMedix, LLC, a US-based cardiac monitoring company, launched the RhythmStar SL cardiac monitor, a third-generation wearable cardiac monitoring device developed to enhance patient experience and clinical performance. The device incorporates a compact lead configuration, an IPX6-rated waterproof design, extended battery life, and built-in cellular connectivity that automatically transmits ECG data to the cloud without requiring patients to return the device for analysis. Additionally, when integrated with the company's Augmented Arrhythmia Intelligence platform, the monitor combines advanced detection algorithms with a multi-layered review process to deliver accurate arrhythmia detection while supporting timely clinical decision-making.
In December 2024, SmartCardia SA, a Switzerland-based medtech company, acquired Cardiomedix for an undisclosed amount. Through this acquisition, SmartCardia aims to establish a fully integrated, end-to-end cardiac monitoring ecosystem in the United States by combining its FDA-cleared wearable ECG technology and cloud analytics with Cardiomedix's accredited diagnostic testing services to strengthen its clinical service delivery capabilities. Cardiomedix Inc. is a US-based company that provides cardiac monitoring devices and remote monitoring services.
Major companies operating in the cardiac monitoring devices market are Abbott Laboratories, AliveCor Inc., Asahi Kasei Corporation, Baxter International Inc., BIOTRONIK SE & Co. KG, BPL Medical Technologies Private Limited, Boston Scientific Corporation, Edwards Lifesciences Corporation, Fukuda Denshi Co. Ltd., GE HealthCare Technologies Inc., iRhythm Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Masimo Corporation, Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Omron Healthcare Inc., OSI Systems Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
North America was the dominant region in the cardiac monitoring devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the cardiac monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiac monitoring devices market consists of sales of products including electrocardiogram (ECG) devices, Holter monitors, event monitors, implantable loop recorders, cardiac telemetry devices, and wearable cardiac monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.